Shanghai United Imaging Healthcare Co Ltd
SSE:688271
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
92.81
150.08
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Shanghai United Imaging Healthcare Co Ltd stock under the Base Case scenario is 105.51 CNY. Compared to the current market price of 134.5 CNY, Shanghai United Imaging Healthcare Co Ltd is Overvalued by 22%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Shanghai United Imaging Healthcare Co Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for Shanghai United Imaging Healthcare Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Shanghai United Imaging Healthcare Co Ltd
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Shanghai United Imaging Healthcare Co., Ltd. is a rapidly emerging player in the medical imaging and healthcare technology sector, rooted in innovation and a commitment to enhancing healthcare delivery across the globe. Founded in 2011, the company has made significant strides in developing advanced imaging systems that deliver high-quality diagnostics while being cost-effective. Their product line spans a variety of technologies, including magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound machines, catering to the diverse needs of hospitals and clinics. With a strong emphasis on research and development, United Imaging has cultivated a robust intellectual property p...
Shanghai United Imaging Healthcare Co., Ltd. is a rapidly emerging player in the medical imaging and healthcare technology sector, rooted in innovation and a commitment to enhancing healthcare delivery across the globe. Founded in 2011, the company has made significant strides in developing advanced imaging systems that deliver high-quality diagnostics while being cost-effective. Their product line spans a variety of technologies, including magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound machines, catering to the diverse needs of hospitals and clinics. With a strong emphasis on research and development, United Imaging has cultivated a robust intellectual property portfolio, allowing it to remain at the forefront of technological advancements in the healthcare industry.
As the global demand for healthcare services continues to escalate, fueled by an aging population and rising chronic disease prevalence, United Imaging positions itself as a key contributor to enhanced patient outcomes. The company's strategic partnerships with various healthcare institutions and focus on international expansion highlight its ambition to penetrate key markets beyond China. Investors looking for opportunities in the healthcare sector may find United Imaging particularly appealing, as it is well-poised to leverage its innovative capabilities and growing market presence to drive long-term growth. With a vision centered on making advanced healthcare accessible to all, the company's success story is not just about financial metrics—it's about transforming patient care through technology.
Shanghai United Imaging Healthcare Co., Ltd. is a leading provider in the medical imaging and healthcare equipment sector. The company's core business segments include:
-
Medical Imaging Equipment: This segment focuses on the research, development, manufacturing, and sale of various imaging modalities. Key products include MRI (Magnetic Resonance Imaging) machines, CT (Computed Tomography) scanners, PET (Positron Emission Tomography) equipment, ultrasound machines, and X-ray systems. This is a crucial area as imaging technology is fundamental for diagnosis and treatment monitoring.
-
Healthcare IT Solutions: United Imaging also develops integrated healthcare information technology solutions. This includes software platforms for data management, imaging diagnostics, and clinical decision support systems. The aim is to enhance efficiency, accuracy, and collaboration in healthcare management.
-
Radiation Therapy Equipment: The company manufactures advanced radiation therapy systems that are essential for cancer treatment. This segment encompasses linear accelerators and other technologies designed for precise targeting of tumors.
-
Healthcare Services: In addition to equipment, United Imaging may provide after-sales services, maintenance, and training for healthcare professionals to ensure that their products are optimally used and maintained.
-
International Market Expansion: United Imaging has been focusing on expanding its presence in international markets, which involves not only selling equipment globally but also adapting technologies to meet the regulatory and clinical needs of various countries.
These segments combined position Shanghai United Imaging Healthcare as a significant player in the global healthcare technology sector, contributing to improved patient care and outcomes through innovation in medical imaging and related services.
Shanghai United Imaging Healthcare Co., Ltd. (United Imaging) has several unique competitive advantages over its rivals in the healthcare technology sector. Here are some key aspects:
-
Vertical Integration: United Imaging controls a significant portion of its supply chain, from R&D to manufacturing. This vertical integration allows for greater quality control, cost efficiency, and quicker response times to market demands, giving them an edge over competitors who may rely more on third-party suppliers.
-
Innovative Product Portfolio: The company focuses on cutting-edge technologies and has a robust pipeline of innovative products in medical imaging and healthcare solutions, such as MRI, CT, and ultrasound systems. Their commitment to R&D enables them to stay ahead in terms of technology and product features.
-
Customization and Flexibility: United Imaging offers highly customizable solutions to meet specific needs of different healthcare providers. This adaptability is a significant advantage in a diverse healthcare market where differing requirements can vary widely.
-
Strong Domestic Market Position: With a substantial foothold in the Chinese healthcare market, United Imaging benefits from an understanding of local needs and regulations, which allows them to tailor their offerings effectively. This strong position also provides a stable revenue base to fund further innovation.
-
Strategic Partnerships: United Imaging has established various collaborations with academic institutions and research organizations, which enhances their technological capabilities and accelerates product development.
-
Cost Competitiveness: Due to efficiencies realized from local production and a lower labor cost in China, United Imaging can offer competitive pricing for its products, making it an attractive option for both domestic and international buyers.
-
Focus on Healthcare IT and Integration: Alongside their imaging equipment, the company is increasingly investing in healthcare IT solutions, such as AI-based diagnostics and integrated healthcare systems, which position it to meet modern demands for digital transformation in healthcare.
-
Growing Global Presence: While primarily known in China, United Imaging has been expanding its presence in international markets. This global diversification not only boosts revenue but also reduces dependency on any single market.
-
Regulatory Advantage: With established relationships and experience navigating the regulatory landscape in China, United Imaging can more swiftly maneuver through necessary compliance compared to international competitors entering the Chinese market.
-
Government Support: Being a Chinese company, United Imaging may benefit from state investments and support in the healthcare sector, fostering growth and facilitating research efforts in a strategic industry.
These competitive advantages enable United Imaging to maintain a strong position in the healthcare technology landscape while effectively competing against both domestic and international rivals.
Shanghai United Imaging Healthcare Co., Ltd., as a prominent player in the healthcare technology sector, faces several risks and challenges in the near future:
-
Regulatory Compliance: The medical technology industry is heavily regulated. Changes in regulations, both in China and internationally, can pose challenges in terms of compliance, costs of approvals, and market access.
-
Market Competition: The healthcare technology sector is rapidly evolving, with intense competition from both domestic and international companies. Innovations and price competition can impact market share and profit margins.
-
Technological Advancements: Keeping pace with rapid technological changes is crucial. Failure to innovate or adopt new technologies can render existing products obsolete, impacting the company’s competitive edge.
-
Supply Chain Disruptions: Global supply chain issues, particularly highlighted during the COVID-19 pandemic, can affect the availability of components and materials, leading to production delays and increased costs.
-
Economic Conditions: Economic downturns or uncertainties in China or globally can impact healthcare budgets, leading to lower investment in medical technology and affecting sales.
-
Intellectual Property Risks: The healthcare technology sector involves significant R&D investment. Risks related to patent infringements, theft of intellectual property, and challenges in enforcing IP rights can affect the company’s innovation efforts.
-
Cybersecurity Threats: As healthcare technology becomes increasingly interconnected, the risk of cyberattacks and data breaches grows. Protecting sensitive patient data is crucial for maintaining trust and compliance.
-
Public Perception and Trust: Any negative publicity or incidents related to safety or efficacy can harm the company’s reputation, affecting customer trust and sales.
-
Global Expansion Challenges: If the company aims to expand into new international markets, it may face legal, cultural, and operational challenges that can complicate its global strategy.
-
Talent Acquisition and Retention: The healthcare technology sector requires highly skilled professionals. Attracting and retaining talent in an increasingly competitive job market can be a challenge.
-
Healthcare Policy Changes: Changes in healthcare policies, both domestically and internationally, such as reimbursement rates or public health initiatives, could impact demand for United Imaging’s products.
Each of these factors represents potential obstacles that the company must navigate to maintain its growth trajectory and ensure its long-term success in the crowded and evolving healthcare technology space.
Revenue & Expenses Breakdown
Shanghai United Imaging Healthcare Co Ltd
Balance Sheet Decomposition
Shanghai United Imaging Healthcare Co Ltd
Current Assets | 20.7B |
Cash & Short-Term Investments | 10.8B |
Receivables | 5.2B |
Other Current Assets | 4.8B |
Non-Current Assets | 6B |
Long-Term Investments | 108.5m |
PP&E | 4B |
Intangibles | 1.1B |
Other Non-Current Assets | 741.1m |
Current Liabilities | 6.5B |
Accounts Payable | 2.4B |
Accrued Liabilities | 759.3m |
Short-Term Debt | 275.4m |
Other Current Liabilities | 3B |
Non-Current Liabilities | 632m |
Long-Term Debt | 90.6m |
Other Non-Current Liabilities | 541.3m |
Earnings Waterfall
Shanghai United Imaging Healthcare Co Ltd
Revenue
|
11.5B
CNY
|
Cost of Revenue
|
-5.9B
CNY
|
Gross Profit
|
5.6B
CNY
|
Operating Expenses
|
-3.7B
CNY
|
Operating Income
|
1.9B
CNY
|
Other Expenses
|
63.6m
CNY
|
Net Income
|
2B
CNY
|
Free Cash Flow Analysis
Shanghai United Imaging Healthcare Co Ltd
CNY | |
Free Cash Flow | CNY |
Profitability Score
Profitability Due Diligence
Shanghai United Imaging Healthcare Co Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Score
Shanghai United Imaging Healthcare Co Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Shanghai United Imaging Healthcare Co Ltd's solvency score is 85/100. The higher the solvency score, the more solvent the company is.
Score
Shanghai United Imaging Healthcare Co Ltd's solvency score is 85/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Shanghai United Imaging Healthcare Co Ltd
According to Wall Street analysts, the average 1-year price target for Shanghai United Imaging Healthcare Co Ltd is 143.64 CNY with a low forecast of 111.5 CNY and a high forecast of 177.45 CNY.
Dividends
Current shareholder yield for Shanghai United Imaging Healthcare Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Shanghai United Imaging Healthcare Co., Ltd. engages in the development and production of medical imaging and radiotherapy equipment; as well as the provision of medical intelligent digital solutions. The company is headquartered in Shanghai, Shanghai and currently employs 7,302 full-time employees. The company went IPO on 2022-08-22. Its products include Magnetic Resonance Imaging Systems (MR), X-ray Computed Tomography (CT), X-ray Imaging Systems (XR), Molecular Imaging Systems (PET/CT, PET/MR), Medical Linear Accelerator Systems (RT) and Life Science Instruments. In the field of digital diagnosis and treatment, the Company provides United Imaging Medical Cloud services to realize cloud collaboration of equipment and applications and sharing of medical resources, and to provide comprehensive solutions for end customers.
Contact
IPO
Employees
Officers
The intrinsic value of one Shanghai United Imaging Healthcare Co Ltd stock under the Base Case scenario is 105.51 CNY.
Compared to the current market price of 134.5 CNY, Shanghai United Imaging Healthcare Co Ltd is Overvalued by 22%.